# DESCRIPTION

## RELATED INFORMATION

- motivate atherosclerosis treatment
- summarize current treatments
- limitations of current treatments
- introduce MTP as target
- motivate miR-30c as solution
- summarize miR-30c benefits

## BRIEF SUMMARY

- introduce miR-30c analogs and compositions

## DETAILED DESCRIPTION

- define technical terms
- specify numerical limitations
- describe polynucleotide sequences
- define singular and plural forms
- describe double stranded RNA complex
- specify therapeutically effective amount
- describe administration and effects

### EXAMPLES

- introduce RNA interference-based therapy
- motivate miR-30c analogs
- describe modified miR-30c duplexes
- summarize thermal stability results
- describe CD spectra
- evaluate efficacy of modified miRs in reducing apoB secretion
- introduce pseudouridine modification
- describe synthesis of A-series analogs
- evaluate efficacy of A-series analogs
- introduce GalNAc modification
- describe synthesis of GalNAc-modified analogs
- evaluate efficacy of GalNAc-modified analogs
- describe concentration-dependent studies
- evaluate effects on MTP activity
- introduce phosphorothioate modification
- evaluate efficacy of phosphorothioate-modified analogs
- synthesize GalNAc derivatives
- synthesize RNA strands
- perform cell culture studies
- measure apoB and apoA1 levels
- measure miR-30c and MTP transcript levels
- measure MTP protein levels and activity
- perform statistical analysis
- study effects of analog C2 on Huh-7 cells
- study effects of analog C2 on human primary hepatocytes
- measure lipid levels in human primary hepatocytes

